Suministro de Nintedanib (DOE) e Idarucizumab (DOE)
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Feb 3,Expired
- Award
- Agreement
- Buying goodsover 1 year
Brief
OSAKIDETZA - Servicio Vasco de Salud - OSI Barrualde-Galdakao (Impulsora) ha modificado un contrato con BOEHRINGER INGELHEIM ESPAÑA, S.A. para el suministro de Nintedanib (DOE) e Idarucizumab (DOE) en España. El contrato tiene una duración de 1 año y un valor final de 4.622.604 €.
Farmasøytisk engroshandel
Result
- Boehringer Ingelheim España, S. A.Winner
- 0Number of tenders received
- €4,622,604Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora)
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Suministro de Nintedanib (DOE) e Idarucizumab (DOE)
Contact
Servicio de Farmaciacontrata@osakidetza.eus- ResultType
- Araba/ÁlavaLocation
- 33600000Main codePharmaceutical products